Share Name Share Symbol Market Type Share ISIN Share Description
Premaitha LSE:NIPT London Ordinary Share GB00BN31ZD89 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.125p -1.59% 7.75p 7.50p 8.00p 7.875p 7.75p 7.875p 256,811.00 08:05:53
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Software & Computer Services 2.5 -12.1 6.0 1.3 17.68

Premaitha Share Discussion Threads

Showing 4276 to 4298 of 4300 messages
Chat Pages: 172  171  170  169  168  167  166  165  164  163  162  161  Older
DateSubjectAuthorDiscuss
24/1/2017
08:53
Really getting bored of this..
timojelly
19/1/2017
22:19
Thanks hjb.
elrico
19/1/2017
15:43
elrico; to avoid any doubt it is the chap who works for Hardman who deals with the Premaitha work/report, sorry for any confusion!
hjb1
19/1/2017
13:27
HJB - You stated it was from someone "working with Hardman" NOT Hardman. October, senior moment on my part, it was a ref to July CC of course. I don't mean to be disingenuous to you, just cautious. I don't post often and more than BSS would like I would wager, but can we at least agree to stick to NIPT and not get involved with the loonies that invested in the CTAG fraud and now badger bait TW because he called the fraud for what it IS! There must be 5-6 CTAG gimps posting here and all seemingly attempting to discolour NIPT by TW association.
elrico
19/1/2017
10:59
No,I don't. You cannot research future court rulings on exporting to avoid a patent ruling you lost. It is as Hardman said 'it could be possible' no more than that. or put another way, then yes, he did research and realised it might/may/could be possible. What I say is equally possible.....and this is PAID FOR RESEARCH/REPORT which must be taken into account. It's the best foot forward requiring a basis of fact/possibilities. imv it may be misleading to read too much into this "possiblity"and I just hope we win if it goes to court because I have little confidence with this particular Hardman hope if we lost. aimho n'est pas?
twix386
19/1/2017
10:55
Twix, I would think the guy would have researched heavily the possibility to circumvent before he published it,don't you?.let's face it all they are doing is taking a blood sample m'lud, and nobody has a patent for that! lol
hjb1
19/1/2017
10:54
I would settle for an out of court too. There was a time I wanted to go to court and win. That was when things looked and felt and was stated as much better and there was less concern and never ending commercial damage. Illumina, if they settle are bound to wait to the last minute to cause us maximum damage. Facilitated as we delayed for a year to partner Ariosa which is only relevant to invalidity argument - not the 'we do not infringe anyway'. I always thought the delay if we had a strong case that we did not infringe, was a mistake and I remain (at 8p and terrible contract delivery) of the same view except that subsequently it's since been stated we now do not expect a binary outcome. ahhhhh
twix386
19/1/2017
10:47
yes, ultimately it will only be the opinion of the courts, if it ever gets that far? Whilst it is his opinion he still would want to keep a bit of credibility even if they have been paid. I would settle for an "out of court" any day..
hjb1
19/1/2017
10:42
Re Hardman report. My conclusion is we have a good chance to win and I am hopefull on the data that supports a win and must remain confidential, but I am less convinced by the export of our results to Taiwan for analysis argument though I am sure IONA can be used in these other markets where there is no Illumina patent, of course. The area I take issue with the paid for view is because even Hardman say at best they believe "it could" be possible. I foresee Illumina seeking a ruling on export of the core data out of Europe specifically to circumvent patents? Illumina would of course look at this development and seek any and all opportunities to confront this. Yourgene is currently doing this method themselves, as Hardman make sure to tell us, but of course not a single core test result Yourgene collects comes from Europe where there is a patent in force, so that comparrision is almost irrelevant imv. It is felt no more than a reasonable possibility for us if we lose the patent and Hardman are imv talking it up. If we lose the patent I feel it is also at least a reasonable possibility that Illumina will have plugged this possibility or at the very least would then seek to stop us exporting based on their victory not allowing a clear breach of the spirit of the ruling. It's a good story to tell and has possibilties, but it's one sided with caveats imho. It looks likely IF Illumina settle, it will only be late in the day. So if we run that late we would rather go to court? I bet we will settle if offered acceptable terms at any time and assuming we have a strong enough case as told that would be disapointing - not as disappointing as losing though. lol
twix386
19/1/2017
10:08
hi - I hope the Doc from Hardman is on the money but it is just an opinion and what's more, one that's effectively been paid for. He/she will inevitably have to defer to the court decision in due course or a pre-court settlement (not my preferred option tbh) so as topically interesting as it is - it remains just that.
gooosed
19/1/2017
09:53
gooosed, but I have an authenticated source!! Not comfortable in divulging though, having said that he couldn't have thought what he sent was a problem to put into the public domain and did not ask it to stay confidential so....
hjb1
19/1/2017
09:25
elrico - fwiw I agree 100%, without an authenticated source it's nothing more than an anonymous post on a BB. Hopefully reality is not too far away but til the approaching Court case precipitates action it's more of the doldrums imho.
gooosed
19/1/2017
09:20
Premaitha takeover, bring it on. 50p plus please.
timojelly
19/1/2017
01:13
yes, nice and tight!! and it's not what I'm telling you, it's what the good man at Hardman is telling us and I have no reason to doubt him. As I said he has researched this in detail and must be very very sure of himself to actually put that email out in the public domain.I have to admit that I was a bit shocked myself with the revelations when I first read it and if he is correct then it's massively positive imo.
hjb1
19/1/2017
00:43
ok, jings better strap myself in then if that's what you're telling me.
the monkster
19/1/2017
00:23
yawn yawn!, yes that's exactly what happens to me when I see your posts! lmao. Like the man says, unlikely Illumina will win, he has obviously unearthed some juicy stuff on Illumina for the legals to halt the publication ..and obviously knows more than you will ever know...about what is going on..take it on board!
hjb1
19/1/2017
00:13
yawn yawn - just pay us out some liquidation proceeds while you are able to please
the monkster
19/1/2017
00:06
elrico, the "source" is from Hardman as stated , it's legit, believe it! What's with the Oct D day, the court case is July?
hjb1
18/1/2017
23:59
Post 4276 - though a welcome change from the children hurling mud at a blogger, it means nothing without a source. It could well be written by a semi literate PI. However, I do hope there is truth to it and perhaps mid 2017 we may get a broad hint how this will go ahead of October D-day.
elrico
10/1/2017
22:03
Now that is very interesting!
hurricane.
10/1/2017
20:48
NOTE : - For anyone with their money and heart in NIPT's future. Below is an extract of an e-mail exchange between a respected investor and someone working with Hardman........ and it should give a filip to all NIPT'rs after such a dreadful 2016. Game-changer to come in 2017 re. court battle with Illumna !! Investor (bakky) "I emailed Hardman's regarding the patent issue and his reply was very interesting.It seems the patent CAN be got around, as I said if that is the case then that is MASSIVE imo! his reply below, Dear Mr ..... First, I have undertaken a complete review of the patent situation in Europe and came to the conclusion that Illumina has a very weak case. However, I have not been allowed to publish this work because the lawyers stated that I had supplied the entire defense and did not want this in the public domain. So I think that Premaitha has a good chance of winning its case. However, I am also aware of time and costs and could understand a situation where Premaitha settles out of court on the right terms - ie close to the royalty rate that is paid by its 'friends' as opposed to the $75 per test that Illumina wants to charge Great Ormond Street Hospital. Notwithstanding this, Illumina's patents are not covered in several territories in SE Asia. This provides two things. First, it means that IONA can be used in these markets without risk of patent infringement. Secondly, it means that maternal blood samples can be spun down and analysed in, say Europe, and the results sent to Taiwan for analysis (as Yourgene is currently doing), thus avoiding Illumina's European patents. Therefore, I feel that this is a realistic possibility in the unlikely event that the Illumina patents are upheld. I hope that this helps. Dr ........
dyfiman
10/1/2017
16:49
hjb Unfortunately yes, he is still in business. My only wonder is how ADVFN allow him to continue to use their website.
blackss
10/1/2017
16:33
ha ha! not a fan then? lol.Anyway does anyone pay a blind bit of notice to him nowadays?
hjb1
Chat Pages: 172  171  170  169  168  167  166  165  164  163  162  161  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:41 V: D:20170124 23:21:21